Interventions for lowering plasma homocysteine levels in dialysis patients

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2004-01-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD004683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Homocysteine and Multiple Health Outcomes: An Outcome-Wide Umbrella Review of Meta-analyses and Mendelian Randomization Studies

  2025cites this paper
• Uncovering Hyperhomocysteinemia: Global Risk Patterns and Molecular Disruption in Brain and Vascular Health

  2025cites this paper
• Investigating the synergistic effects of gamma-glutamyl transferase with homocysteine, ferritin, and uric acid in patients with type II diabetes mellitus

  2024cites this paper
• Homocysteine, Vitamin B12 and Folate Level: Possible Risk Factors in the Progression of Chronic Heart and Kidney Disorders

  2023influential citation
• Demand for Water-Soluble Vitamins in a Group of Patients with CKD versus Interventions and Supplementation—A Systematic Review

  2023cites this paper
• Blood Thiol Redox State in Chronic Kidney Disease

  2022cites this paper
• Effect of nutritional supplementation on mortality in peritoneal dialysis patients: A meta‐analysis

  2022cites this paper
• Association between homocysteinemia and mortality in CKD: A propensity-score matched analysis using NHANES-National Death Index

  2022cites this paper
• Vitamin metabolism and requirements in chronic kidney disease and kidney failure

  2022cites this paper
• Homocysteine-Lowering Interventions in Chronic Kidney Disease

  2021cites this paper
• The weak correlation between serum vitamin levels and chronic kidney disease in hospitalized patients: a cross-sectional study

  2021cites this paper
• The Association between Homocysteinemia and Mortality in Pre-dialysis CKD patients: A Propensity-Score Matched Analysis Using NHANES-National Death Index Link

  2021cites this paper
• The significance of homocysteine in patients with hypertension

  2021cites this paper
• CHANGES IN THE EXPRESSIONS OF SERUM HOMOCYSTEINE, FOLIC ACID AND VITAMIN B12 IN DIABETIC NEUROGENIC BLADDER AND THE RELATIONSHIP WITH BLADDER FUNCTION

  2020cites this paper
• Diabetic Retinopathy: Mitochondria Caught in a Muddle of Homocysteine

  2020cites this paper
• Clinical Interventions and All-Cause Mortality of Patients with Chronic Kidney Disease: An Umbrella Systematic Review of Meta-Analyses

  2020cites this paper
• The association of genotype polymorphisms with vascular access patency in hemodialysis patients

  2019cites this paper
• Atherosclerosis in Chronic Kidney Disease.

  2019cites this paper
• Vitamin B complex mitigates cardiac dysfunction in high‐methionine diet‐induced hyperhomocysteinemia

  2018cites this paper
• Update on Hypertension Management 2018 , 19 , nr . 67 ENDOTHELIAL FACTORS IN THE PATHOGENESIS AND TREATMENT OF CHRONIC KIDNEY DISEASE

  2018cites this paper
• Associations of dietary macronutrients and micronutrients with the traditional and nontraditional risk factors for cardiovascular disease among hemodialysis patients

  2018cites this paper
• Hyperhomocysteinemia: How Does it Affect the Development of Cardiovascular Disease?

  2018cites this paper
• Colpire l'infiammazione per migliorare la prognosi del paziente dializzato

  2017cites this paper
• Effects of atorvastatin and simvastatin on oxidative stress in diet-induced hyperhomocysteinemia in Wistar albino rats: a comparative study

  2017cites this paper
• Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension

  2017cites this paper
• Hyperhomocysteinemia in patients with chronic kidney disease and its relationship with the functional status of the cardiovascular system

  2017cites this paper
• Cardiovascular Disease in Dialysis Patients

  2017cites this paper
• Homocysteine and Non-Cardiac Vascular Disease.

  2017cites this paper
• Endothelial Factors in The Pathogenesis and Treatment of Chronic Kidney Disease Part II: Role in Disease Conditions. A Joint Consensus Statement from the ESH Working Group on Endothelin and Endothelial Factors And The Japanese Society of Hypertension

  2017cites this paper
• Targeting Immunity in End-Stage Renal Disease

  2017cites this paper